Free Trial

Biogen (BIIB) SEC Filings & 10K Form

Biogen logo
$146.47 -0.92 (-0.62%)
(As of 12/20/2024 05:45 PM ET)

Recent Biogen SEC Filings

DateFilerForm TypeView
12/09/2024
3:56 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:57 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
9:33 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
3:23 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
10:20 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/30/2024
3:45 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
3:31 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
5:55 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
11:11 AM
Biogen (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
10/07/2024
6:08 PM
Biogen (Issuer)
Minor Lloyd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/12/2024
6:31 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
5:00 AM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
12:00 PM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
5:40 PM
Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
Form SC 13G/A
08/01/2024
5:55 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:01 PM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
4:06 PM
Biogen (Issuer)
DORSA CAROLINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:13 PM
Biogen (Issuer)
Freire Maria C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:14 PM
Biogen (Issuer)
HAWKINS WILLIAM A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:15 PM
Biogen (Issuer)
Patolawala Monish D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:16 PM
Biogen (Issuer)
LANGER SUSAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:18 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:19 PM
Biogen (Issuer)
Mantas Jesus B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:20 PM
Biogen (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:08 PM
Biogen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/03/2024
7:00 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
4:15 PM
Biogen (Filer)
Form ARS
04/24/2024
3:15 PM
Biogen (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2024
6:02 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
4:01 PM
Biogen (Filer)
Form PRE 14A
04/03/2024
7:24 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
7:11 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
9:08 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
6:54 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
9:12 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:31 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:33 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:36 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:39 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:27 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
8:28 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry. 
02/21/2024
8:29 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
9:24 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
8:13 PM
Biogen (Issuer)
Rowinsky Eric K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:56 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:00 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:01 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:03 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:04 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:06 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:14 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:07 AM
Biogen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:07 PM
Biogen (Filed by)
Denali Therapeutics Inc. (Subject)
Form SC 13G/A
02/12/2024
6:11 PM
Biogen (Filed by)
SANGAMO THERAPEUTICS, INC (Subject)
Form SC 13G/A
02/12/2024
10:21 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2024
10:10 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
9:50 AM
Biogen (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/09/2024
7:11 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:12 PM
Biogen (Issuer)
Grogan Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:14 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:16 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
6:56 PM
Biogen (Issuer)
Viehbacher Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
6:59 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:01 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:03 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:06 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:08 PM
Biogen (Issuer)
Keeney Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:38 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
9:44 AM
Biogen (Subject)
Singhal Priya (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2024
4:34 PM
Biogen (Issuer)
MCDONNELL MICHAEL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:35 PM
Biogen (Issuer)
Murphy Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:36 PM
Biogen (Issuer)
Singhal Priya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:27 PM
ALEXANDER SUSAN H (Reporting)
Biogen (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:30 PM
Biogen (Issuer)
Gregory Ginger (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:31 PM
Biogen (Issuer)
Izzar Rachid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:33 PM
Biogen (Issuer)
Kramer Robin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:52 PM
Biogen (Issuer)
Patolawala Monish D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BIIB) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners